Get the Stockscreener App
10.06
0.40%
-0.04
After Hours:
10.06
Oaktree Acquisition Corp Iii Life Sciences stock is traded at $10.06, with a volume of 406.
It is down -0.40% in the last 24 hours and up +0.60% over the past month.
Oaktree Acquisition Corp III Life Sciences is a blank check company.
See More
Previous Close:
$10.10
Open:
$10.06
24h Volume:
406
Relative Volume:
0.02
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.20%
1M Performance:
+0.60%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$10.06
$10.06
1-Week Range:
$10.05
$10.22
52-Week Range:
$9.99
$10.22
Oaktree Acquisition Corp Iii Life Sciences Stock (OACCU) Company Profile
Name
Oaktree Acquisition Corp Iii Life Sciences
Sector
Industry
Phone
-
Address
-
Compare OACCU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OACCU
Oaktree Acquisition Corp Iii Life Sciences
|
10.06 | 0 | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
7.04 | 2.04B | 3.13B | 50.80M | 555.00M | 0.00 |
|
OBDE
Blue Owl Capital Corp Iii
|
14.86 | 1.83B | 244.17M | 216.39M | -461.29M | 0.00 |
|
AACT
Ares Acquisition Corporation Ii
|
10.90 | 681.25M | 0 | 16.92M | -1.35M | 0.00 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.43 | 449.58M | 0 | 1.30M | 0 | 0.00 |
|
EQV
Eqv Ventures Acquisition Corp
|
9.94 | 443.05M | 0 | 0 | 0 | 0.00 |
Oaktree Acquisition Corp Iii Life Sciences Stock (OACCU) Latest News
Oaktree Acquisition Corp. III Life Sciences’ (NASDAQ:OACCU) Quiet Period Will End on December 3rd - Defense World
Pacific Valley Bancorp (OTCMKTS:PVBK) and Pinnacle Financial Partners (NASDAQ:PNFP) Critical Comparison - Defense World
Trinity Investments Acquires The Standard, London Alongside Oaktree and Partners Group - Business Wire
Oaktree Acquisition Corp. III Life Sciences’ US$175 Million Initial Public Offering - Global Legal Chronicle
Special Purpose Acquisition Company (SPAC) News and Analysis - SPACInsider
White & Case advises underwriters on Oaktree Acquisition Corp. III Life Sciences’ US$175 million IPO - White & Case LLP
U.S. IPO Weekly Recap: Sizable Tech And Biotech IPOs Are Joined By A Flurry Of Small Names - Seeking Alpha
Spirit Aero losses deepen, burns cash as Boeing strike bites - Yahoo Canada Finance
Deal Watch: Big Week for Private Equity, Private Credit and Kirkland - Law.com
US IPO Weekly Recap: Standard Aero Soars In 7-IPO Week, While Big Tech Names Join Pipeline - Seeking Alpha
IPO NewsUS IPO Weekly Recap: Standard Aero soars in 7-IPO week, while big tech names join pipeline - Renaissance Capital
Envestnet approves Bain acquisition, Warburg Pincus leads $125m Series E - Alternatives Watch
Exclusive | Oaktree Spins Out Transportation-Infrastructure Group - The Wall Street Journal
Special Purpose Acquisition Companies - Ropes & Gray LLP
IRA Capital Acquires 237,000 Square-Foot Life Science/R&D Campus in Columbus - Newsfile
PE Weekly: Investment Bank Spins Out a New PE Firm - Middle Market Growth
Big M&A deals of 2023, From jerrycans to cheeseheads - Plastics News
Why Danaher Is One Of My Favorite Long-Term Investments (NYSE:DHR) - Seeking Alpha
Spotlight: Golden Triangle Offices & Laboratories - Savills
Redevelopment of Canary Wharf office building into life sciences space gets green light - BE News
Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital and Novo Holdings | PRTK Stock News - StockTitan
Record Q1 for Golden Triangle life sciences real estate investment - Insider Media
Melissa Sawyer - Sullivan & Cromwell LLP
Chad D. Ehrenkranz - Sidley Austin LLP
Harrow Announces New $100 Million Secured Credit Facility with Oaktree - Business Wire
SPACs in Healthcare: The Hot Ticket has Cooled off - Managed Healthcare Executive
UK Life Sciences and Healthcare Newsletter - Dechert LLP
Money Moves: With acquisition, DC's EveryAction is now part of a social impact-focused SaaS company valued at $2B - Technical.ly
How does Hims & Hers make money? - VatorNews
Direct Lending: Benefits, Risks and Opportunities - Oaktree Capital
A look back at the how tech changed the pharma landscape in 2020 - Mobihealth News
Axa IM acquires life sciences real estate developer Kadans - Funds Europe Magazine
Joel L. Rubinstein - White & Case LLP
Four IT companies merge to form digital powerhouse Avenga - Consultancy.eu
Silverpeak, Legacy, Oaktree Acquire Ohio Data Centers - Globe St.
Silverpeak, Legacy, and Oaktree Acquire Portfolio of Data Center Campuses in Cleveland and Cincinnati - Business Wire
Matthew S. Arenson, P.C. - Kirkland & Ellis LLP
Brookfield Asset Management (BAM) 10K Form and SEC Filings 2024 - MarketBeat
Global Healthcare Private Equity and Corporate M&A Report 2018 - Bain & Company
Oaktree Acquisition Corp Iii Life Sciences Stock (OACCU) Financials Data
There is no financial data for Oaktree Acquisition Corp Iii Life Sciences (OACCU). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.10%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):